© 2022 MJH Life Sciences and Drug Topics. All rights reserved.
© 2022 MJH Life Sciences™ and Drug Topics. All rights reserved.
September 12, 2022
Cancer care is expensive, but pharmacists can help.
September 06, 2022
Patients who received the chemotherapies paclitaxel and docetaxel were at an increased risk of adverse events of the eye.
August 26, 2022
More of these treatments have been approved, but supply chain issues and cost remain obstacles.
August 25, 2022
Researchers report that half of the online pharmacies are rogue operations that may operate without a license or have other serious shortcomings.
August 16, 2022
The researchers attributed low adherence to oral anti-cancer medications for blood cancer and certain other cancers to high monthly out-of-pocket among several other reasons.
August 10, 2022
New research suggests there was a 53% greater 5-year risk of cardiovascular disease in men with type 2 diabetes who received a GnRH agonist for prostate cancer compared with their counterparts who did not receive GnRH agonists.
August 05, 2022
This is the first approved therapy targeted to patients with the HER2-low breast cancer subtype. Its approval comes four months ahead of its PDUFA action date.
July 14, 2022
The specialty drug pipeline includes first- and next-in- class drugs across the oncology and immunology spaces.
June 16, 2022
Bar code medication administration has been moved beyond inpatient areas, but compliance may require improvement.
June 14, 2022
The pipeline includes next-in-class treatments for melanoma, NSCLC, breast cancer, and multiple myeloma.